Disease-Modifying Therapies for Alzheimer’s Disease: Global Markets
Disease-Modifying Therapies for Alzheimer’s Disease: Global Markets
Report Includes
- Analysis of the current global markets for disease-modifying therapies for Alzheimer’s disease (AD)
- Analyses of the global market trends, with market revenue data (sales figures) from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Estimates of the market’s size and revenue prospects for the global market, accompanied by a market share analysis based on molecule type, drug classification, therapeutic application, mechanism of action, and region
- Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects, and the impacts of macroeconomic variables
- Discussion of the underlying opportunities and potential in the disease-modifying therapies market
- Insights derived from Porter’s Five Forces model and global value chain analysis
- Information on products that are currently available for the diagnosis and treatment of Alzheimer’s, as well as the promising new drug candidates and diagnostic imaging agents
- Review of key marketed products, clinical trials, competitive scenario and R&D activities
- An analysis of patents, emerging trends and the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Profiles of the leading companies
